HTN:RDN - The Next Chapter

Bringing new options to blood pressure control

A channel devoted to the latest evidence and exploration of Renal Denervation as a proven complementary therapy in the global fight against the World's largest silent killer. Look out for live cases, breaking data, heated debate and a ground-breaking documentary telling the whole story of RDN so far.

Highlighted Event

Renal Denervation: Moving from research to clinical practice

  • 1H

Join this roundtable to hear Dr. Justin Davies, Prof Konstantinos Tsioufis, and Prof. Roland Schmieder discuss the latest ESH Position Paper on Renal Denervation. Updated proposed recommendations was deemed necessary, by the ESH, after the publication of a set of new pivotal sham-controlled randomized clinical trials (RCTs), which provided important information about the efficacy and safety of endovascular device-based renal denervation (RDN) for hypertension treatment, positioning RDN as a third pillar for hypertension treatment.

Add to calendar Add to calendar
View Highlights



Download all the results of this pivotal Late Breaker, including:
Trial Results Presentation
Trial Results Slides
Supporting Material
Shareable 1-Pagers

  • 14 files
  • 48.8 MB

Featured Experts

David Kandzari

Doctor Kandzari is Director of Interventional Cardiology, Piedmont Heart Institute and Chief...

Read More

Felix Mahfoud

Professor Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and...

Read More

Joachim Weil

Prof. Dr. Weil is Director of the Cardiovascular center at the Sana Clinic in Lübeck. His...

Read More

Michael Böhm

Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the...

Read More

Peter Sever

Prof. Peter Sever is Professor of Clinical Pharmacology and Therapeutics at Imperial College...

Read More

Costas Tsioufis

Dr. Tsioufis, Professor of Cardiology, National and Kapodistrian University of Athens, Director...

Read More